Concepedia

Publication | Open Access

Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease

DOIFull Paper Access

109

Citations

21

References

1998

Year

Tilo Andus, K. W. Ecker, Andreas Raedler, K. Loeschke, Mathias Plauth, J. Rasenack, Alexander N.R. Weber, M Gierend, Klaus Ewe, J Schölmerich,
Gut

Abstract

Oral pH modified release budesonide at a dose of 3 x 1 mg/day is not effective for maintaining steroid induced remission in Crohn's disease.

References

YearCitations

Page 1